Pharmaceuticals and money -- elements in the debate over a cost-disclosure bill. (Photo: O.S. Fisher, Shutterstock)
An attempt to force drug makers to disclose their costs and profits for drugs that sell wholesale for more than $10,000 annually was derailed in the Legislature, facing strong opposition from an industry targeting similar measures in other states. The forces battling over the bill include some of the most powerful in California.
California’s TV and film tax incentive appears as popular as ever, despite a rash of negative news coverage of an FBI undercover sting of a state senator in which an industry tax break figured as a lure. “The FBI could have picked any topic from any industry to mount a sting,” Assemblymember Raul Bocanegra, D-Los Angeles, said recently at the Hollywood Chamber of Commerce’s 2nd Annual State of the Industry Conference.(Photo: Stan Rudich)